Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017


News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Bayer : hires law firm to probe Monsanto data collection

share with twitter share with LinkedIn share with facebook
share via e-mail
05/21/2019 | 11:10am EDT
FILE PHOTO: Headquarters and main plant of German pharmaceutical and chemical maker Bayer AG in Leverkusen

BERLIN (Reuters) - Bayer on Tuesday hired law firm Sidley Austin to investigate a Europe-wide data collection scheme run by its Monsanto unit, which targeted journalists, politicians and other stakeholders to influence the debate on pesticides.

Bayer last week admitted that Monsanto, which it acquired for $63 billion last year, had gathered non-public information as part of the campaign, which French media said sought to influence the public debate on pesticides and genetically modified products.

Bayer faces potentially heavy litigation costs from U.S. lawsuits in which plaintiffs claim that its Roundup weedkiller, which contains glyphosate, causes cancer. Bayer disputes this.

In a Q&A document posted on its website on Tuesday, Bayer said U.S public relations and marketing agency FleishmanHillard, on behalf of Monsanto, had mapped stakeholders in France, Germany, Italy, Netherlands, Poland, Spain, and United Kingdom as well as stakeholders related to EU institutions.

Sidley Austin will investigate how many stakeholders were included in those files and whether people from other countries could also be affected, Bayer said.

The law firm would then contact affected people, most of them journalists, politicians and scientists, no later than by the end of the coming week.

French prosecutors said they had opened an inquiry after newspaper Le Monde filed a complaint alleging that Monsanto had kept a file of 200 names in hopes of influencing their positions.

Bayer has ended its PR collaboration with FleishmanHillard, but continues to work with the firm on marketing projects.

Bayer shares have shed more than 40 percent since a first adverse U.S. judgment on Roundup last August, leaving the company with a market capitalization smaller than the price it paid for Monsanto.

(This story removes reference to class-action lawsuits, paragraph 3)

(Reporting by Tassilo Hummel; Editing by Alexandra Hudson)

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on BAYER AG
06/24BAYER : initiates Phase III trial of Aflibercept to prevent blindness in prematu..
06/24BAYER : and AlphaBio Control sign distribution agreement for innovative biologic..
06/19GLOBAL MARKETS LIVE : Viacom, Apple, Siemens, Boeing…
06/18Fosun Eyeing Move for Bayer Animal-Health Business -Bloomberg
06/18BAYER : Roche wins Japan approval for personalised cancer drug Rozlytrek
06/17BAYER : Studies Herbicide Shift As It Looks Beyond Roundup
06/15BAYER : Earmarks over $5 Billion for New Weed-Management Strategies in the Next ..
06/15BAYER : raising bar for transparency and sustainability
06/14BAYER : to Invest Billions in Weedkillers in Wake of Roundup Controversy--Update
06/14BAYER : Deutsche Bahn to Phase out Glyphosate -WirtschaftWoche
More news
Financials (€)
Sales 2019 46 540 M
EBIT 2019 8 175 M
Net income 2019 3 479 M
Debt 2019 37 729 M
Yield 2019 5,19%
P/E ratio 2019 14,59
P/E ratio 2020 11,87
EV / Sales 2019 1,92x
EV / Sales 2020 1,80x
Capitalization 51 607 M
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 77,3 €
Spread / Average Target 40%
EPS Revisions
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-8.62%56 539
JOHNSON & JOHNSON10.10%348 981
PFIZER0.05%233 072
ROCHE HOLDING LTD.13.50%227 848
NOVARTIS21.44%220 893
MERCK AND COMPANY11.91%206 641